Crinetics Pharmaceuticals Vs. Biomea Fusion Industry Stock Comparison

Buy

56

CRNX
Crinetics Pharmaceuticals

Last Price:

56.06

Seasonality Move:

7.41%

Sell

14

BMEA
Biomea Fusion

Last Price:

6.43

Seasonality Move:

25.94%

Buy

56

Crinetics Pharmaceuticals (CRNX) is a Buy

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

The current Crinetics Pharmaceuticals [CRNX] share price is $57.03. The Score for CRNX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
CRNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

14

Biomea Fusion (BMEA) is a Sell

Is Biomea Fusion a Buy, Sell or Hold?

The current Biomea Fusion [BMEA] share price is $6.38. The Score for BMEA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
BMEA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

The Crinetics Pharmaceuticals share price today is $57.03
The current trend is moderately bearish and CRNX is experiencing slight buying pressure.

BMEA Stock Price Chart

What is Biomea Fusion's stock price today?

The Biomea Fusion share price today is $6.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMEA is experiencing slight buying pressure.

CRNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.19	Buy
Relative Strength Index (14 RSI):	50.98	Buy
Chaikin Money Flow:	179702	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(55.91 - 59.51)	Sell
Bollinger Bands (100):	(49.93 - 56.83)	Buy

BMEA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.01	Sell
Relative Strength Index (14 RSI):	24.23	Sell
Chaikin Money Flow:	191778	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.05 - 11.19)	Sell
Bollinger Bands (100):	(5.48 - 9.86)	Sell

CRNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	56.76	Buy
20-day SMA:	57.4	Sell
50-day SMA:	55.16	Buy
200-day SMA:	48.81	Buy
8-day EMA:	56.65	Buy
20-day EMA:	56.94	Buy
50-day EMA:	55.57	Buy
200-day EMA:	48.37	Buy

BMEA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	6.78	Sell
20-day SMA:	8.53	Sell
50-day SMA:	9.35	Sell
200-day SMA:	10.06	Sell
8-day EMA:	6.86	Sell
20-day EMA:	8.01	Sell
50-day EMA:	8.63	Sell
200-day EMA:	9.92	Sell

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.18 per share.

Biomea Fusion Earnings Growth & BMEA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $0.80 per share.

Crinetics Pharmaceuticals Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomea Fusion Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):